Incidence and Prognostic Impact of Heart Failure Hospitalization During Follow-Up After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction

Tomohiko Taniguchi(Kyoto University), Takeshi Kimura(Municipal Hirakata City Hospital), Minoru Horie(Nagahama City Hospital), Shuichiro Kaji(Kansai Electric Power Hospital), Satoshi Shizuta(Kyoto University), Takao Kato(Juntendo University Hospital), Koh Ono(Kyoto University), Kenji Andò(Kokura Memorial Hospital), Hiroki Shiomi(Kyoto University), Hirotoshi Watanabe(Municipal Hirakata City Hospital), Kazushige Kadota(Kurashiki Central Hospital), Yoshihisa Nakagawa(Shiga University of Medical Science), Takeshi Morimoto(Hyogo Medical University), Yutaka Furukawa(Kobe City Medical Center General Hospital), Naritatsu Saito(Foundation for Biomedical Research)
The American Journal of Cardiology
March 22, 2017
10.1016/j.amjcard.2017.03.013
Cited by 41

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death
|Nature Genetics|2013|550
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
|New England Journal of Medicine|1996|507
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363